XTL Biopharmaceuticals Ltd. (TLV:XTLB)
Israel · Delayed Price · Currency is ILS · Price in ILA 2.000
0.00 (0.00%)
Aug 3, 2026, 5:13 PM IDT
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of 19.66 million as of August 3, 2026. Its market cap has decreased by -56.26% in one year.
Market Cap
19.66M
Enterprise Value
19.42M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.00
ChartMarket Cap Chart
Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 19.66M, a decrease of -97.56%. That is a compound annual growth rate of -16.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 19.66M | -13.43% |
| Dec 31, 2025 | 22.71M | -72.15% |
| Dec 31, 2024 | 81.53M | 327.50% |
| Dec 31, 2023 | 19.07M | -14.63% |
| Dec 29, 2022 | 22.34M | -52.02% |
| Dec 30, 2021 | 46.56M | -7.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geffen Residence & Renewal | 322.94M |
| Bonus BioGroup | 309.56M |
| Matricelf | 72.59M |
| BioLineRx | 41.94M |
| Clal Biotechnology Industries | 40.47M |
| BioLight Life Sciences | 31.56M |
| Can-Fite BioPharma | 22.11M |
| Purple Biotech | 18.65M |